Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform

@inproceedings{Whitbeck2013SecondGD,
  title={Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform},
  author={Matthew G Whitbeck and R. Joseph Applegate},
  booktitle={Clinical Medicine Insights. Cardiology},
  year={2013}
}
  • Matthew G Whitbeck, R. Joseph Applegate
  • Published in
    Clinical Medicine Insights…
    2013
  • Medicine
  • Everolimus-eluting stents (EES) represent the next generation of drug-eluting stents (DES). Important design modifications include thin strut stent backbones, less inflammatory and more biocompatible polymers, and lower drug dosing. The cobalt chromium EES fluoropolymer XIENCE V stent has been the most extensively studied of such stents. In animal models, this stent demonstrated minimal vessel inflammation, a biologically active endothelium with strut coverage similar to a bare metal stent, and… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    1
    Twitter Mention

    Citations

    Publications citing this paper.
    SHOWING 1-8 OF 8 CITATIONS

    Neoatherosclerosis after Drug-Eluting Stent Implantation: Roles and Mechanisms

    VIEW 1 EXCERPT
    CITES BACKGROUND

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 32 REFERENCES